-
article
Olivera-Ugarte SM, Bolduc M, Laliberté-Gagné MÈ and Blanchette LJ, Garneau C, Fillion M, Savard P, Dubuc I, Flamand L, Farnòs O, Xu X, Kamen A, Gilbert M, Rabezanahary H, Scarrone M, Couture C, Baz M, Leclerc D
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection
Nanomedicine
44 2022.
-
article
Laliberte-Gagne ME, Bolduc M, Garneau C, Olivera-Ugarte SM, Savard P, Leclerc D
Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity
Vaccines (Basel)
9 (1), 2021.
-
article
Langley J, Pastural E, Halperin S, McNeil S, ElSherif M, MacKinnon-Cameron D, Ye L, Grange C, Thibodeau V, Cailhier JF, Lapointe R, McElhaney J, Martin L, Bolduc M, Laliberté-Gagné ME, Leclerc D, Savard P
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccin…
Vaccines (Basel)
8 (3), 2020.
